Abstract
Nitric oxide (NO) donors were used to investigate the effect of NO on and the role of cyclic GMP in the regulation of human natural killer (NK) cell function. NO-producing drugs, molsidomine and its metabolite 3-morpholinesydnonimine (SIN-1), inhibited NK cell-mediated cytotoxicity significantly at 0.04-5 mM. At 1 mM, SIN-1 completely inhibited NK cell activity while molsidomine decreased NK cell-mediated cytolysis by 35% of the control value. These data suggest that NO from exogenous NO-donors may down-regulate NK cell cytotoxic function. The stimulatory effect of interferon-gamma (IFN-gamma) on human NK cell-mediated killing could not overtake the NK cell inhibition induced by the NO releasing drugs, indicating different modes of action for IFN-gamma and SIN-1. The results in the present study also showed that SIN-1 (1 mM) stimulated cyclic GMP production 37-fold in NK cells. In the presence of 0.5 mM IBMX, a phosphodiesterase inhibitor, the increase in cyclic GMP was even more pronounced, demonstrating a relation between cyclic GMP stimulation and NK cell inhibition by SIN-1. Further evidence for mediation via cyclic GMP was provided by the finding that methylene blue (20 microM), an inhibitor of soluble guanylate cyclase, d...Continue Reading
References
Oct 15, 1992·Biochemical and Biophysical Research Communications·Y Nunokawa, S Tanaka
Nov 1, 1992·Circulation Research·Y GengE Holme
Mar 16, 1991·Lancet·K G ParkO Eremin
Jun 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·P KubesD N Granger
Jul 3, 1990·European Journal of Pharmacology·H SchröderK Schrör
Oct 25, 1990·Nature·D S BredtS H Snyder
Jan 24, 1991·Nature·K Shibuki, D Okada
Mar 1, 1991·Immunology Today·F Y Liew, F E Cox
Aug 1, 1991·European Journal of Clinical Investigation·S Moncada, E A Higgs
Nov 1, 1990·Hypertension·L J Ignarro
Jan 1, 1989·Journal of Cardiovascular Pharmacology·H Bohn, K Schönafinger
Aug 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·D SalveminiJ R Vane
Dec 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·L J IgnarroG Chaudhuri
Apr 1, 1988·Endocrinology·D C LeitmanF Murad
Nov 30, 1988·Biochemical and Biophysical Research Communications·J B HibbsE M Rachlin
Nov 29, 1988·Biochemistry·M A MarlettaJ S Wishnok
Jun 11, 1987·Nature·R M PalmerS Moncada
Feb 1, 1972·Analytical Biochemistry·I WeinrybS M Hess
Sep 1, 1983·Cellular Immunology·S I AbramsZ Brahmi
Mar 1, 1981·Cellular Immunology·D G FischerH S Koren
Jan 1, 1980·Journal of Immunological Methods·T Timonen, E Saksela
Aug 1, 1994·Cellular Immunology·M G CifoneA Santoni
Aug 12, 1993·Nature·S A LiptonJ S Stamler
Sep 1, 1993·The Journal of Clinical Investigation·T OhigashiJ W Fisher
Citations
Oct 2, 1998·International Journal of Immunopharmacology·Z Zidek, K Masek
Nov 1, 1995·Scandinavian Journal of Immunology·L XiaoG A Qureshi
Oct 20, 2009·Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons·Wioletta Ratajczak-WronaLeszek Piotrowski
Oct 31, 2009·Immunopharmacology and Immunotoxicology·Wioletta Ratajczak-WronaMagdalena Marcinczyk
Nov 24, 1998·Infection and Immunity·M G SchwachaT K Eisenstein